(Q44846741)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16307009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

CDKN2B methylation is an independent poor prognostic factor in newly diagnosed acute promyelocytic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16307009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16307009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Lau JS

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16307009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Wong KF

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16307009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Kwong YL

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16307009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16307009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16307009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16307009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16307009%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

149-151

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16307009%20AND%20SRC:MED&resulttype=core&format=json

Acute promyelocytic leukemia: evolving therapeutic strategies

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404052

Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404052

Hypermethylation of GpG islands in the promoter region of p15(INK4b) in acute promyelocytic leukemia represses p15(INK4b) expression and correlates with poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404052

Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404052

Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404052

Methylation of p15 and p16 genes in acute promyelocytic leukemia: potential diagnostic and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404052

inferred from DOI database lookup

7 January 2021

based on heuristic

Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404052

inferred from DOI database lookup

7 January 2021

based on heuristic

Serial studies of methylation of CDKN2B and CDKN2A in relapsed acute promyelocytic leukaemia treated with arsenic trioxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404052